The Vanguard Group Discloses Stake in Mural Oncology plc

The Vanguard Group, Inc. has released a disclosure under Rule 8.3 of the Irish Takeover Panel Act, regarding its position in Mural Oncology plc. As of August 25, 2025, Vanguard holds 4.47% of Mural Oncology's $0.01 ordinary shares, amounting to 771,539 shares. This disclosure is crucial for transparency in the context of takeover regulations.

In recent dealings, Vanguard reported the sale of 32 ordinary shares at a unit price of $2.06. No derivative transactions or other dealings involving Mural Oncology's securities have been disclosed. Additionally, Vanguard stated no indemnity or option arrangements related to these securities.

No supplemental Form 8 accompanies this disclosure, indicating no new agreements or derivative transactions. Such disclosures are standard practice for entities with significant interests in relevant securities.